{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:16:33Z","timestamp":1788333393382,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004823","name":"Nagoya University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004823","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Langerhans cell sarcoma (LCS), malignant indeterminate dendritic cell tumor (IDCT), and interdigitating dendritic cell sarcoma (IDCS) are rare malignant neoplasms that originate from antigen-presenting conventional dendritic cells (cDCs). These tumors, collectively termed cDC sarcoma in this study, have been reported only rarely in association with myeloid malignancies. We collected five cases of cDC sarcoma coexisting with acute myeloid leukemia (AML) or myelodysplastic neoplasm with increased blasts (MDS-IB), conducted clinicopathologic and genetic analyses, and compared these with four reported cases. Among the nine cases, histological subtypes included LCS (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20096), malignant IDCT (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20092), and IDCS (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091), whereas associated myeloid neoplasms comprised AML (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20098) and MDS-IB2 (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091). Clinically, five patients developed cDC sarcoma and AML\/MDS-IB nearly simultaneously, whereas four developed AML after cDC sarcoma. Six patients died or required palliative care within 2\u00a0years, whereas three achieved complete remission or long-term survival. Nodal involvement predominated (8\/9 cases). Immunohistochemically, cDC sarcomas frequently expressed myeloid markers (CD33 5\/5; CD34 2\/8). Conversely, myeloid blasts expressed histiocytic\/monocytic-associated markers including CD68 and lysozyme in 3\/5 cases, whereas S-100 and CD1a were focally expressed in only one case. Genetically, next-generation sequencing revealed shared mutations\u2014including those in the RAS\u2013MAPK pathway\u2014in four of five paired cases. Further, one case harbored a shared\n                    <jats:italic>KMT2A<\/jats:italic>\n                    rearrangement, which supports a common clonal origin. These results indicate a close biological relationship between cDC sarcoma and myeloid neoplasms and highlight the importance of recognizing concomitant myeloid disease in patients with cDC sarcoma.\n                  <\/jats:p>","DOI":"10.1007\/s00428-026-04699-5","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:58:55Z","timestamp":1788332335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic and clinicopathologic analysis of conventional dendritic cell sarcomas coexisting with myeloid neoplasms"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8748-6325","authenticated-orcid":false,"given":"Kanae","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-858X","authenticated-orcid":false,"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"4699_CR1","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.3389\/fimmu.2018.03176","volume":"9","author":"TA Patente","year":"2018","unstructured":"Patente TA, Pinho MP, Oliveira AA, Evangelista GCM, Bergami-Santos PC, Barbuto JAM (2018) Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy. Front Immunol 9:3176. https:\/\/doi.org\/10.3389\/fimmu.2018.03176","journal-title":"Front Immunol"},{"key":"4699_CR2","unstructured":"Chan J, Alaggio R, Coupland SE (2024) Histiocytic and dendritic cell neoplasms: IntroductionWHO Classification of Tumours, 5th Edition: Haematolymphoid Tumours. International Agency for Research on Cancer, Lyon, pp."},{"key":"4699_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.5021\/ad.2017.29.5.614","volume":"29","author":"Y Li","year":"2017","unstructured":"Li Y, Wang TT, Zhang ZH, Wang L (2017) Aggressive indeterminate dendritic cell tumor mimicking scalp angiosarcoma. Ann Dermatol 29:614\u2013617. https:\/\/doi.org\/10.5021\/ad.2017.29.5.614","journal-title":"Ann Dermatol"},{"key":"4699_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3960\/jslrt.24031","volume":"64","author":"R Yamada","year":"2024","unstructured":"Yamada R, Komohara Y (2024) Histiocytic neoplasms: a brief review and differential diagnosis. J Clin Exp Hematop 64:156\u2013165. https:\/\/doi.org\/10.3960\/jslrt.24031","journal-title":"J Clin Exp Hematop"},{"key":"4699_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04230-2","author":"A Dezzani","year":"2025","unstructured":"Dezzani A, Punziano C, Berti E, Bonometti A (2025) Langerhans cell sarcoma is a clinically, biologically, and prognostically heterogeneous \u201cmalignant\u201d histiocytosis: a systematic review of 88 cases from the literature. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-025-04230-2","journal-title":"Virchows Arch"},{"key":"4699_CR6","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1182\/bloodadvances.2024013545","volume":"8","author":"N Ozkaya","year":"2024","unstructured":"Ozkaya N, Melloul Benizri S, Venkataraman G, Karai LJ, Fraitag S, Razanamahery J, Pittaluga S, Battistella M, Pack S, Le Pelletier F, Xi L, Moreau A, Lee I, Helias-Rodzewicz Z, Donadieu J, Haroche J, Raffeld M, Jaffe ES, Emile JF (2024) Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms. Blood Adv 8:5796\u20135805. https:\/\/doi.org\/10.1182\/bloodadvances.2024013545","journal-title":"Blood Adv"},{"key":"4699_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/his.15127","volume":"84","author":"PG Kemps","year":"2024","unstructured":"Kemps PG, Kester L, Scheijde-Vermeulen MA, van Noesel CJM, Verdijk RM, Diepstra A, van Marion AMW, Dors N, van den Bos C, Bruggink AH, Hogendoorn PCW, van Halteren AGS (2024) Demographics and additional haematologic cancers of patients with histiocytic\/dendritic cell neoplasms. Histopathology 84:837\u2013846. https:\/\/doi.org\/10.1111\/his.15127","journal-title":"Histopathology"},{"key":"4699_CR8","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1182\/bloodadvances.2024015208","volume":"9","author":"C Bigenwald","year":"2025","unstructured":"Bigenwald C, Roos-Weil D, Pages A, Helias-Rodzewicz Z, Copie-Bergman C, Nashvi M, Khneisser P, Parrens M, Traverse-Glehen A, Ray-Coquard I, Ysebaert L, Marchand T, Razanamahery J, Charlotte F, Neel A, Damaj G, Dion J, Nazal-Traissac EM, Tardy S, Salmeron G, Monjanel H, Idbaih A, Heritier S, Haroche J, Donadieu J, Emile JF (2025) Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France. Blood Adv 9:2530\u20132541. https:\/\/doi.org\/10.1182\/bloodadvances.2024015208","journal-title":"Blood Adv"},{"key":"4699_CR9","doi-asserted-by":"publisher","first-page":"100352","DOI":"10.1016\/j.modpat.2023.100352","volume":"37","author":"S Sadigh","year":"2024","unstructured":"Sadigh S, DeAngelo DJ, Garcia JS, Hasserjian RP, Hergott CB, Lane AA, Lovitch SB, Lucas F, Luskin MR, Morgan EA, Pinkus GS, Pozdnyakova O, Rodig SJ, Shanmugam V, Tsai HK, Winer ES, Zemmour D, Kim AS (2024) Cutaneous manifestations of myeloid neoplasms exhibit broad and divergent morphologic and immunophenotypic features but share ancestral clonal mutations with bone marrow. Mod Pathol 37:100352. https:\/\/doi.org\/10.1016\/j.modpat.2023.100352","journal-title":"Mod Pathol"},{"key":"4699_CR10","first-page":"320","volume":"19","author":"KSA Uchida","year":"2018","unstructured":"Uchida KSA, Kondo Y (2018) A case of Langerhans Cell sarcoma Complicated by Myelodysplastic Syndrome. Nihonkensaketsuekigakkaishi 19:320\u2013327","journal-title":"Nihonkensaketsuekigakkaishi"},{"key":"4699_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1532\/IJH97.04142","volume":"81","author":"T Kawase","year":"2005","unstructured":"Kawase T, Hamazaki M, Ogura M, Kawase Y, Murayama T, Mori Y, Nagai H, Tateno M, Oyama T, Kamiya Y, Taji H, Kagami Y, Naoe T, Takahashi T, Morishima Y, Nakamura S (2005) CD56\/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases. Int J Hematol 81:323\u2013329. https:\/\/doi.org\/10.1532\/IJH97.04142","journal-title":"Int J Hematol"},{"key":"4699_CR12","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.11406\/rinketsu.56.2456","volume":"56","author":"K Hamaguchi","year":"2015","unstructured":"Hamaguchi K, Hashimoto A, Fujimi A, Kanisawa Y, Shibata T, Nakajima C, Hayasaka N, Yamada S, Okuda T, Minami S, Kamihara Y, Ohshima K, Kato J (2015) [Langerhans cell sarcoma developing acute myeloid leukemia after achieving complete response by THP-COP]. Rinsho Ketsueki 56:2456\u20132461. https:\/\/doi.org\/10.11406\/rinketsu.56.2456","journal-title":"Rinsho Ketsueki"},{"key":"4699_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12185-013-1336-6","volume":"97","author":"YZ Jiang","year":"2013","unstructured":"Jiang YZ, Dong NZ, Wu DP, Xue SL (2013) Interdigitating dendritic cell sarcoma presenting simultaneously with acute myelomonocytic leukemia: report of a rare case and literature review. Int J Hematol 97:657\u2013666. https:\/\/doi.org\/10.1007\/s12185-013-1336-6","journal-title":"Int J Hematol"},{"key":"4699_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12185-008-0063-x","volume":"87","author":"K Sumida","year":"2008","unstructured":"Sumida K, Yoshidomi Y, Koga H, Kuwahara N, Matsuishi E, Karube K, Oshima K, Gondo H (2008) Leukemic transformation of Langerhans cell sarcoma. Int J Hematol 87:527\u2013531. https:\/\/doi.org\/10.1007\/s12185-008-0063-x","journal-title":"Int J Hematol"},{"key":"4699_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/DAD.0b013e3182661c0b","volume":"35","author":"MJ Sagransky","year":"2013","unstructured":"Sagransky MJ, Deng AC, Magro CM (2013) Primary cutaneous langerhans cell sarcoma: a report of four cases and review of the literature. Am J Dermatopathol 35:196\u2013204. https:\/\/doi.org\/10.1097\/DAD.0b013e3182661c0b","journal-title":"Am J Dermatopathol"},{"key":"4699_CR16","volume-title":"WHO classification of tumours of haematolymphoid tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board (2022) WHO classification of tumours of haematolymphoid tumours. International Agency for Research on Cancer, Lyon, France"},{"key":"4699_CR17","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1182\/blood.2021011921","volume":"139","author":"T Yasuda","year":"2022","unstructured":"Yasuda T, Sanada M, Kawazu M, Kojima S, Tsuzuki S, Ueno H, Iwamoto E, Iijima-Yamashita Y, Yamada T, Kanamori T, Nishimura R, Kuwatsuka Y, Takada S, Tanaka M, Ota S, Dobashi N, Yamazaki E, Hirose A, Murayama T, Sumi M, Sato S, Tange N, Nakamura Y, Katsuoka Y, Sakaida E, Kawamata T, Iida H, Shiraishi Y, Nannya Y, Ogawa S, Taniwaki M, Asou N, Hatta Y, Kiyoi H, Matsumura I, Horibe K, Mano H, Naoe T, Miyazaki Y, Hayakawa F (2022) Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1\/2 mutations. Blood 139:1850\u20131862. https:\/\/doi.org\/10.1182\/blood.2021011921","journal-title":"Blood"},{"key":"4699_CR18","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1111\/cas.14552","volume":"111","author":"T Yasuda","year":"2020","unstructured":"Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, Saito A, Miyoshi H, Ishikawa Y, Asou N, Usuki K, Hirabayashi S, Kato M, Ri M, Handa H, Ishida T, Shibayama H, Abe M, Iriyama C, Karube K, Nishikori M, Ohshima K, Kataoka K, Yoshida K, Shiraishi Y, Goto H, Adachi S, Kobayashi R, Kiyoi H, Miyazaki Y, Ogawa S, Kurahashi H, Yokoyama H, Manabe A, Iida S, Tomita A, Horibe K (2020) Clinical utility of target capture-based panel sequencing in hematological malignancies: a multicenter feasibility study. Cancer Sci 111:3367\u20133378. https:\/\/doi.org\/10.1111\/cas.14552","journal-title":"Cancer Sci"},{"key":"4699_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jamadermatol.2023.4360","volume":"160","author":"S Beckmann","year":"2024","unstructured":"Beckmann S, Kliffen M, Huijben A, Dubbink HJ, Sandberg Y (2024) Concurrent langerhans cell histiocytosis and acute myeloid leukemia without clonal relationship. JAMA Dermatol 160:115\u2013116. https:\/\/doi.org\/10.1001\/jamadermatol.2023.4360","journal-title":"JAMA Dermatol"},{"key":"4699_CR20","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s00277-019-03824-6","volume":"98","author":"A Muhammed","year":"2019","unstructured":"Muhammed A, Ahmed ARH, Maysa H, Mohamed AES, Abd-ElLateef AA, Elnakib E (2019) New insights inside the interdigitating dendritic cell sarcoma-pooled analysis and review of literature. Ann Hematol 98:2641\u20132651. https:\/\/doi.org\/10.1007\/s00277-019-03824-6","journal-title":"Ann Hematol"},{"key":"4699_CR21","doi-asserted-by":"publisher","first-page":"100268","DOI":"10.1016\/j.modpat.2023.100268","volume":"36","author":"A Ravindran","year":"2023","unstructured":"Ravindran A, Dasari S, Ruan GJ, Artymiuk CJ, He R, Viswanatha DS, Abeykoon JP, Zanwar S, Young JR, Goyal G, Go RS, Rech KL, Mayo Clinic-The University of Alabama at Birmingham Histiocytosis Working G (2023) Malignant histiocytosis comprises a phenotypic spectrum that parallels the lineage differentiation of monocytes, macrophages, dendritic cells, and langerhans cells. Mod Pathol 36:100268. https:\/\/doi.org\/10.1016\/j.modpat.2023.100268","journal-title":"Mod Pathol"},{"key":"4699_CR22","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM, Histiocyte S (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127:2672\u20132681. https:\/\/doi.org\/10.1182\/blood-2016-01-690636","journal-title":"Blood"},{"key":"4699_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3109\/01913123.2015.1120838","volume":"40","author":"YX Ru","year":"2016","unstructured":"Ru YX, Dong SX, Zhao SX, Liang HY, Wang HJ, Hu X, Mi YC, Wang JX (2016) Histiocytic differentiation in acute monocytic leukemia. Ultrastruct Pathol 40:18\u201323. https:\/\/doi.org\/10.3109\/01913123.2015.1120838","journal-title":"Ultrastruct Pathol"},{"key":"4699_CR24","doi-asserted-by":"publisher","first-page":"e70044","DOI":"10.1002\/2056-4538.70044","volume":"11","author":"D Nann","year":"2025","unstructured":"Nann D, Schade TC, Overkamp M, Mahmutovic L, Bag E, Forchhammer S, Slotta-Huspenina J, Boudova L, Sotlar K, Quintanilla-Martinez L, Bonzheim I, Fend F (2025) Myeloid sarcoma shows a high frequency of mutations activating the MAPK\/ERK pathway and association with clonal hematopoiesis. J Pathol Clin Res 11:e70044. https:\/\/doi.org\/10.1002\/2056-4538.70044","journal-title":"J Pathol Clin Res"},{"key":"4699_CR25","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1182\/blood-2003-02-0434","volume":"102","author":"C Schoch","year":"2003","unstructured":"Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T (2003) AML with 11q23\/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 102:2395\u20132402. https:\/\/doi.org\/10.1182\/blood-2003-02-0434","journal-title":"Blood"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04699-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04699-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04699-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:58:57Z","timestamp":1788332337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04699-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":25,"alternative-id":["4699"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04699-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.K. has received honoraria from Janssen, Chugai, Takeda, Kyowa Kirin, Otsuka, AbbVie, Genmab, Eisai, AstraZeneca, SymBio, Nippon-Shinyaku, Roche, and Meiji-Seika Pharma, and a research grant from Takeda and Eisai. All other authors have no competing financial or non-financial interests to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}